Skip to content

ABBOTT LABORATORIES

ABT

CIK 0000001800

← back to feed
Revenue (TTM)
$44.03B
+5.7% YoY Q1 Mar 2026
Net Income (TTM)
$5.83B
−51.3% YoY Q1 Mar 2026
EPS Diluted (TTM)
$3.32
−51.3% YoY Q1 Mar 2026
Gross Margin
10.0%
Q1 Mar 2026
Operating Margin
16.2%
Q1 Mar 2026
Net Margin
13.2%
Q1 Mar 2026
Free Cash Flow (TTM)
$3.24B
Q1 Mar 2026
Cash
$6.8B
Q1 Mar 2026
Total Debt
$29.64B
Q1 Mar 2026
Shares Outstanding
1.74B sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings